The central Elephant – Institutional Demand – stands directly on the Turtle, Europe's public infrastructure. In this first Commercialisation Review, I'm going to look at what it means in practice: what his actual role is, and what may happen when the job is done. To find answers I will consider five companies represented on the panel of the third EO Commercialisation Forum in Seville in May 2026; constellr answered questions for this piece; the other four are described from the panel and the public record.
ESA opened the panel session with figures; five invited European EO companies described what the same programme had done for each of them. Everyone agreed that CCM membership works. What interested me the most was the route each company had chosen, and the outcomes that route had brought.
What ESA measured
ESA commissioned London Economics and Novaspace to study the effect across 41 EO companies, roughly half of which had taken part in ESA customer activities.
Revenue was up 81 per cent in the same year and 125 per cent the following year. Companies also reported accelerated constellation development and stronger credibility with customers and investors. And one figure that measures something different from the rest: 67 per cent of European emerging suppliers in the programme said they would have reduced their European involvement without it.
On funding, 73 per cent of total capital raised by Category-1 emerging CCM (Copernicus Contributing Missions) companies between 2015 and 2025 was raised after onboarding. The study itself is not publicly available; these figures come from the Forum presentation.
What the figures show, and what they don't
Before going further, two things are worth noticing.
The revenue rise is stated as inclusive of ESA contract revenue. So part of the 81 to 125 per cent is the contract itself – companies that were paid have more money. What is worth knowing, and what a founder would ask first, is how much of that rise came from customers other than ESA. The slide does not separate them.
The funding figure has a timing problem. The first cohort joined in June 2023. Funding that year was €68 million, down from €122 million in 2022. The 73 per cent is carried by 2024 and 2025 – the same two years in which European space funding rose sharply across the sector and defence budgets expanded. Post-CCM and post-2023 are the same period, so the data cannot separate the programme from the market.
ESA says as much on the slide: the benefits are expected over the longer term, and the estimates need continued monitoring. That is the proper qualification, and it is the first thing to disappear once a headline number is in circulation.
Five routes
Kuva Space holds a five-year contract as sole provider of hyperspectral data to CCM. At the forum, the company said that calibration and evaluation to European standards had helped open doors to customers globally. In July its US subsidiary was selected by NASA under the CSDA programme. This route treats the designation as a certification: measured against a published standard, and therefore portable.
Unseenlabs joined in 2025 and brought the first RF data into the programme. The company said CCM opened European agencies that had not been reachable before. The same instrument, pointed the other way – inward, towards institutions rather than outward towards markets.
constellr answered my questions for this piece. Hannah Kofler, Product Manager for Image Processing and Data Science, told me the first change was credibility, and that it was noticeable almost immediately in conversations. "CCM provided an early institutional demand signal: for customers, it demonstrated that our data was reliable, that constellr was a stable provider, and that the technology was worth integrating for the long term. For investors, it showed real demand, an established procurement pathway and the potential for recurring revenue."
Since signing, constellr has raised €75 million and grown past 100 employees. On whether CCM and the DLR contract do different jobs, her answer was that both are anchor contracts serving the same purpose – bridging the gap between technological innovation and market adoption through credibility, stability and a clear demand signal, but with different reach. "Where CCM goes further is through the scale and reach of the Copernicus ecosystem. It gives us access to a much broader European operational environment, drives technical maturity through demanding and regularly evaluated data-quality standards, and connects us with partners and users across the ecosystem."
Satlantis described the designation as accelerating its shift from optical payload provider to fully integrated mission operator. Its CEO, Juan Tomás Hernani, has said publicly that CCM recognition helped secure investment and played a part in closing a €26 million round. Here the effect landed on the balance sheet.
Aistech Space described CCM as opening doors to customers, and named something none of the others did – the inputs that come from sitting inside the ecosystem.
Faster to the same door
There is one more claim on the same slide, and it is the one I keep coming back to.
ESA puts the European handicap at fifteen months to Series A, assuming two companies raised their seed at the same time. While the American start-up is scaling internationally, the European one is still scaling locally, and by the time it begins to expand the American company is two years ahead. CCM companies, ESA argues, close that gap – reaching each subsequent round earlier than the European baseline.
Suppose that holds. It describes an acceleration in timing, not a change in who is waiting at the other end. In 2025, no growth-stage round in European space was led by a European private investor. Arriving earlier at a stage that Europe struggles to fund is a different achievement from being funded.
What follows
Five companies, five routes: a certification that travels outward, a door that opens inward, an anchor contract with wider reach, a signal to investors, and membership of a network. They do not replace each other. A certification will not close a funding round. An investor signal will not tell a Copernicus service that the data meets specification.
Which is why an average is the wrong thing to plan around. Eighty-one per cent says nothing about which of the five a particular company will get, and the five are not equally available – they depend on what the company sells, who it needs to reach, and what it is short of right now.
So the question I would put to a company considering the application, and to one already inside: what do you need CCM to do for you? One of these five, or something else entirely? If the answer is the designation itself rather than something specific the designation does, that is worth knowing before the form goes in.